Tag : Myasthenia Gravis

Neurology

COVID-19 Linked to Development of Myasthenia Gravis

Newsemia
Three patients with no prior neurologic or autoimmune disorders developed myasthenia gravis within a week after onset of fever from SARS-CoV-2 infection. Medscape Medical News...
Neurology

Guidance management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Newsemia
No data currently exist on how COVID-19 affects people with myasthenia gravis (MG)/LEMS or patients with other diseases on immunosuppressive therapies. However, because most patients...
Neurology

FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome

Newsemia
Amifampridine (Firdapse) is approved for adults with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder characterized by muscle weakness. FDA Approvals Source link...
Neurology

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Newsemia
Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy